Brief: Astria Therapeutics Announces Positive Initial Proof-of-Concept Results From ALPHA-STAR Phase 1b/2 Trial

Astria Therapeutics

25/03/2024 13:34

March 25 (Reuters) - Astria Therapeutics Inc  ATXS.O :
    * ASTRIA THERAPEUTICS ANNOUNCES POSITIVE INITIAL
PROOF-OF-CONCEPT
RESULTS FROM THE ALPHA-STAR PHASE 1B/2 TRIAL OF STAR-0215 FOR
HAE
    * ASTRIA THERAPEUTICS INC: STAR-0215 VERY WELL-TOLERATED
WITH NO
SERIOUS ADVERSE EVENTS AND NO DISCONTINUATIONS
    * ASTRIA THERAPEUTICS INC: STAR-0215 PHASE 3 INITIATION ON
TRACK
FOR Q1 2025, WITH TOP-LINE RESULTS EXPECTED BY YEAR END 2026
    * ASTRIA THERAPEUTICS INC: CURRENT CASH EXPECTED TO FUND
COMPANY
INTO MID-2027

Source text for Eikon:  ID:nBwFsrZ7a 
Further company coverage:  ATXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))